Skip to main content
. 2019 Jun 25;20(12):3108. doi: 10.3390/ijms20123108

Figure 16.

Figure 16

Structure of anti-rat transferrin receptor monoclonal antibody (TfRMAb) engineered to deliver methotrexate (MTX) to the brain by exploiting transferrin receptor-mediated transcytosis. The TfRMAb-MTX conjugate in this example was prepared by oxidation of the carbohydrate groups located on the Fc portion of the TfRMAb to form an aldehyde derivative, which was treated with a hydrazide-functionalized MTX forming a hydrazone-linker between MTX and TfRMAb.